Quietmind Foundation

  • Quietmind Foundation
    • Services
    • Clinical Trials >
      • Light Therapy Single Subject Study
      • Intranasal PBM for Long-COVID
  • Quietmind Associates
    • Home Neurofeedback >
      • Research - IRB Review
    • Phototherapeutics & Neurofeedback >
      • Neurofeedback
      • Photobiomodulation (Light Therapy)
    • Equipment
  • Contact
  • BLOG


​Leading Edge Commentary

Misrepresenting Drug Efficacy in Psychiatry

11/18/2020

0 Comments

 
I've often been asked about the use of medication in treating emotional and behavioral disorders and my standard response is that one should use medication to make it possibl to work in psychotherapy. The idea that drugs are going to resolve emotional challenges without any need to explore these problems consciously and modify ones thinking and other behavior is hard to fathom at best. I've become involved with the use of nondrug noninvasive methods of treatment for the simple reason that they work and have little to no side effects and are cost effective by orders of magnitude especically when considering them being used by the general population. This doesn't mean that I don't include psychotherapeutic work both cognitive and affective in the course of my working with people. I think it is important to educate teh public  as to the corporate drug industry marketing mythology regarding the idea that psychiatric disorders are brain illnesses and can be 'cured' or 'treated' with specialized medications. The Harvard Psychiatry review paper linked here outlines the realities of this myth making effort over the last 30+ years. I'm pleased to see this finally being articulated in an esteemed journal and hope that it has broad impact on the clinicians and those seeking relief from emotional pain that can manifest as physical symptoms. I also hope we can begin to discriminate symptoms born of real biophysical disorders, e.g., traumatic brain injury, heavy metal or mold toxicity, Lyme disease and/or other tick-born illnesses that can cause neuropsychiatric symptoms of almost any that are outlined in the DSMV.  We need to get smarter about all this especially now with all the consequences that will result from millions of people having had COVID 19 infection. It is delusional to think there won't be longer term consequences for our society especially as the evidence becomes available regarding the downstream neurological consequences from COVID 19. 

https://journals.lww.com/hrpjournal/fulltext/2020/11000/messaging_in_biological_psychiatry_.4.aspx

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    QMF News

    Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general. 

    Archives

    June 2025
    March 2025
    January 2025
    December 2024
    October 2024
    July 2024
    March 2024
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    August 2022
    July 2022
    June 2022
    April 2022
    March 2022
    February 2022
    January 2022
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    June 2019
    May 2019
    April 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    April 2018
    March 2018
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    May 2017

    Categories

    All
    Alzheimer's
    Biofeedback
    Breathing Training
    Dementia
    Dementia Treatment
    Drug Free Anxiety Treatment
    Infrared Light
    Light Therapy
    Neurofeedback
    Neurotherapy
    Panic Disorder
    Photobiomodulation
    Relaxation
    TBI Treatment
    Therapy

    RSS Feed

Powered by Create your own unique website with customizable templates.
  • Quietmind Foundation
    • Services
    • Clinical Trials >
      • Light Therapy Single Subject Study
      • Intranasal PBM for Long-COVID
  • Quietmind Associates
    • Home Neurofeedback >
      • Research - IRB Review
    • Phototherapeutics & Neurofeedback >
      • Neurofeedback
      • Photobiomodulation (Light Therapy)
    • Equipment
  • Contact
  • BLOG